Qyuns Therapeutics Co., Ltd. (HKG:2509)
Hong Kong · Delayed Price · Currency is HKD 16.87
+0.05 (0.30%)
Sep 30, 2026, 3:30 PM HKT
Qyuns Therapeutics Market Cap
Qyuns Therapeutics has a market cap or net worth of 3.79 billion as of October 1, 2026. Its market cap has decreased by -49.13% in one year.
Market Cap
3.79B
Enterprise Value
3.35B
Revenue
1.18B
Ranking
n/a
PE Ratio
6.05
Stock Price
16.87
ChartMarket Cap Chart
Since March 20, 2024, Qyuns Therapeutics's market cap has decreased from 5.02B to 3.79B, a decrease of -24.52%. That is a compound annual growth rate of -10.52%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 3.79B | -10.62% |
| Dec 31, 2025 | 4.24B | 158.47% |
| Dec 31, 2024 | 1.64B | -67.33% |
| Mar 20, 2024 | 5.02B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| CK Life Sciences Int'l., (Holdings) | 5.14B |
| Jacobio Pharmaceuticals Group | 4.52B |
| Ocumension Therapeutics | 4.13B |
| Shanghai Bao Pharmaceuticals | 4.11B |
| TransThera Sciences (Nanjing) | 4.10B |
| Hanx Biopharmaceuticals (Wuhan) | 3.71B |
| Mirxes Holding Company | 3.66B |
| Viva Biotech Holdings | 3.03B |